Masashi Iijima
Overview
Explore the profile of Masashi Iijima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadono Y, Nohara T, Kawaguchi S, Kadomoto S, Iwamoto H, Yaegashi H, et al.
Prostate
. 2023 Mar;
83(8):773-780.
PMID: 36879364
Aim: Although many reports have shown that Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) is effective for postoperative urinary continence, the postoperative voiding status and sexual function associated with this technique have...
2.
Nakagawa R, Nohara T, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, et al.
IJU Case Rep
. 2022 Sep;
5(5):334-337.
PMID: 36090925
Introduction: One of the complications of laparoscopic surgery is gas embolism, which has low incidence but high mortality. Carbon dioxide embolism diagnosed during robot-assisted laparoscopic partial nephrectomy has been experienced....
3.
Toriumi R, Yaegashi H, Kadomoto S, Iwamoto H, Iijima M, Kawaguchi S, et al.
Cancer Sci
. 2022 Jul;
114(1):201-210.
PMID: 35838191
Since 2020, the coronavirus disease 2019 pandemic has led to the widespread practice of hand hygiene and wearing face masks, not only among medical personnel, but also among the general...
4.
Kawaguchi S, Izumi K, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, et al.
Cancer Diagn Progn
. 2022 Apr;
1(5):459-464.
PMID: 35403167
Background/aim: The current standard of care for first-line treatment of locally advanced or metastatic urothelial carcinoma (UC) is platinum-based combination chemotherapy. Recently, immune checkpoint inhibitors have been reported to be...
5.
Yaegashi H, Izumi K, Kadomoto S, Iwamoto H, Iijima M, Kawaguchi S, et al.
Cancer Diagn Progn
. 2022 Apr;
1(1):13-17.
PMID: 35399696
Background/aim: We evaluated the clinical outcomes of patients with metastatic germ cell tumors (GCT) treated at our hospital, which belongs to a regional cancer center. Patients And Methods: Data pertaining...
6.
Kawaguchi S, Izumi K, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, et al.
Anticancer Res
. 2022 Mar;
42(4):2105-2111.
PMID: 35347034
Background/aim: We investigated whether coronavirus disease 2019 (COVID-19) vaccination and its adverse events would cause cancer treatment of patients with urological cancer to be postponed or changed. Patients And Methods:...
7.
Kadono Y, Nohara T, Kawaguchi S, Kadomoto S, Iwamoto H, Iijima M, et al.
Sci Rep
. 2022 Mar;
12(1):3975.
PMID: 35273228
Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) exhibits better postoperative urinary continence than conventional RARP (C-RARP) via the anterior approach. However, the reasons behind this are unknown. Herein, early postoperative urinary incontinence...
8.
Nakagawa R, Iwamoto H, Makino T, Kadomoto S, Yaegashi H, Iijima M, et al.
Front Oncol
. 2022 Jan;
11:770067.
PMID: 35070973
It has been reported that chemotherapy drugs and granulocyte colony-stimulating factor (G-CSF) administered on the same day can aggravate neutropenia. In the present study, we investigated the safety of pegfilgrastim...
9.
Nakano T, Nakata H, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, et al.
Sci Rep
. 2021 Nov;
11(1):23007.
PMID: 34837027
Spermatogenesis, which is a continuous process from undifferentiated spermatogonia to spermatozoa in the seminiferous tubules, declines with age. To investigate changes in spermatogenesis with aging, we reconstructed the seminiferous tubules...
10.
Nohara T, Kamijima T, Fukuda R, Kano H, Shimada T, Nakano T, et al.
Photodiagnosis Photodyn Ther
. 2021 Nov;
37:102628.
PMID: 34808397
Background: Photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) has different treatment outcomes across institutions, as seen in conventional TURBT. We retrospectively compared the difference in quality between the...